Related references
Note: Only part of the references are listed.Immortal time bias in pharmacoepidemiology
Samy Suissa
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Increasing glucose levels and BMI predict future heart failure Experience from the Reykjavik Study
I. S. Thrainsdottir et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review
Dean T. Eurich et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk
C. Held et al.
CIRCULATION (2007)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Steven E. Kahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial
H. C. Gerstein et al.
LANCET (2006)
Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure
Finlay A. McAlister et al.
CIRCULATION (2006)
Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study
SH Simpson et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Improved clinical outcomes associated with metformin in patients with diabetes and heart failure
DT Eurich et al.
DIABETES CARE (2005)
Pioglitazone initiation and subsequent hospitalization for congestive heart failure
AJ Karter et al.
DIABETIC MEDICINE (2005)
Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure - An observational study
FA Masoudi et al.
CIRCULATION (2005)
Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K primary care setting
S Maru et al.
DIABETES CARE (2005)
Managing. the patient with diabetes mellitus and heart failure: Issues and considerations
GC Fonarow
AMERICAN JOURNAL OF MEDICINE (2004)
Heart failure prevalence, incidence, and mortality in the elderly with diabetes
AG Bertoni et al.
DIABETES CARE (2004)
The incidence of congestive heart failure in type 2 diabetes
GA Nichols et al.
DIABETES CARE (2004)
The association of fasting glucose levels with congestive heart failure in diabetic adults ≥65 years
JI Barzilay et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?
JJ Meier et al.
HEART (2004)
Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes - A retrospective cohort study
TE Delea et al.
DIABETES CARE (2003)
Evaluating medication effects outside of clinical trials: New-user designs
WA Ray
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes
JA Johnson et al.
DIABETES CARE (2002)
Congestive heart failure in type 2 diabetes - Prevalence, incidence, and risk factors
GA Nichols et al.
DIABETES CARE (2001)
Use of comorbidity scores for control of confounding in studies using administrative data bases
S Schneeweiss et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2000)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Low-dose inhaled corticosteroids and the prevention of death from asthma.
S Suissa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Cardiovascular effects of sulphonylureas:: role of KATP channels
LG Howes
DIABETES OBESITY & METABOLISM (2000)
Congestive heart failure in the United States -: Is there more than meets the I(CD code)?: The Corpus Christi Heart Project
DC Goff et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
